Hans Prenen

1/4 Article of the month: First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase 1 dose exploration. @HPrenen tinyurl.com/23btbhxd

Catch the #LowerGI oncology highlights from #ESMO24 📣 👉 ow.ly/3eYn50U563K Profs. @ChiaraCrem1 & @HPrenen explore how new data from a range of trials could impact clinical practice. Don't miss out! Supported by an independent #MedEd grant from Bayer

Fantastic and insightful lecture from Prof. @HPrenen about Use of immune therapies in GI cancer at #ESSO43 Practice changing news @ESSOnews @OncoAlert

Impact of Exercise on Cancer Recurrence and Survival #ESMO24 @OncoAlert #OncoAlert

@HPrenen #ESMO24 concomitant paper: @DocSacher presents the First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor at today's Presidential Symposium @HPrenen

🚨 New #LowerGI cancer data from #ESMO24 🚨 Profs. @ChiaraCrem1 & @HPrenen joined us at the congress to each share their insights on new rectal & colorectal cancer data from NICHE-2, NICHE-3 & IMHOTEP trials. 📺Watch their video update Supported by Bayer #Meded #CRC

📣 New #LowerGI cancer data from #ESMO24 📣 Profs. @ChiaraCrem1 & @HPrenen joined us at the congress to share their insights on new data from POD1UM-303/InterAACT 2, RAMTAS/IKF643 & POCHI trials. 📺Watch their video update Supported by Bayer #Meded #CRC

📢 #ESMO24 concomitant paper: First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase 1 dose exploration. #ESMO24 @HPrenen tinyurl.com/23btbhxd

Time to move away from radiotherapy in operable GEA #ESMO24 TOPGEAR ➡️ no survival benefit when RT added to periop chemo TOPGEAR + ESOPEC : both great trials with a definitive answer = no more RT ✅Great drugs in development - let's focus on systemic Rx for cure @myESMO

Are you excited for #ESMO24 and the emerging data in GI oncology? Lower GI experts, @ChiaraCrem1 and @HPrenen, will be covering the most hotly anticipated data, including the POD1UM-303 study Watch this space for more over the coming weeks!

Hoewel het voor darmkanker slechts in beperkt aantal gevallen (< 10%) werkt is #immuuntherapie toch zeer grote doorbraak in behandeling kanker! 🍀💪🏻 Prof @HPrenen diensthoofd oncologie @UZAnieuws @UAntwerpen legt alles mooi uit in @HLN_BE 😉 @StopDarmkanker 💙 #kennisdelen

Who made this? 😂

If you are working in the field of GI Cancers and Global Oncology, we invite you to submit to the Article Collection "Treating GI cancers in resource-restricted countries" in Gastrointestinal Oncology: Management and Care. invt.io/1txbhft5wz9 @HPrenen @AORTIC_AFRICA

Alright! It’s that time of the year again. #ASCO24 is about to start. Here are our now classic rules of engagement. (Still don’t know the author to quote and credit). As usual @VoglNY is exempt. @asco @oncoalert @n8pennell @NarjustFlorezMD @Latinamd @DrSGraff @cancermd @mtmdphd @oncology_bg @GlopesMd @SylvesterCancer @JTrentMDPhD #trentselfie @EmilyJonczak @CharuAggarwalMD @montypal @DrChoueiri @ADesaiMD @neerajaiims @OphiraG @COlazagasti @SamuelKareffMD @OncoAlert

@spelmanser @bouwspiegel Ik zal mij dan maar omscholen tot huisarts, vooral de dondernamiddag fietsdag spreekt mij aan :)

@bouwspiegel De nieuwe generatie huisartsen, groepspraktijk, afspraak van maandag tot vrijdag, van 09 u tot 13 en van 14 tot 18u, niet vergeten de donderdagnamiddag is fietsdag.. Alloo 🙄

Hoe verzoen je 55 miljoen euro aan premies om het tekort aan huisartsen op te lossen met een toelatingsexamen dat net als doel heeft minder artsen in de markt te zetten?

Another great submission for the @mybsmo #bsmoxmas Jumper Xmas Campaign by the oncology team from @UZAnieuws @HPrenen @TimonV @lateuwen @A_Verbiest #SevilayAltintas and others 🇧🇪 ⭐️🧑‍🎄🎄📸 @Stkstichting

@JDekervel @CappuynsSarah @LambrechtsDlab Nice paper!

📢📢 PAPER OUT !! 🤔What biology underlies response to #atezobev in #HCC ? 🔬scRNA and scTCR sequencing of tumour and blood samples 🔜tweetorial of the amazing @CappuynsSarah 🙏Fruitful collaboration with @LambrechtsDlab 👀#OpenAccess Paper is here: rdcu.be/dshsE

@BoydSwinburn @drkiwicj Very disappointed ! Was so proud of NZ.

NZ goes from hero to zero: New Zealand scraps world-first smoking ‘generation ban’ to fund tax cuts theguardian.com/world/2023/nov…

A panel of GI oncologists discuss the emerging data likely to impact clinical practice Watch the recorded discussion here 👉cor2ed.com/gi-connect/pro… Organised in partnership with @eChinaHealth and GI CONNECT members @ModestDominik @HPrenen #MedEd

🔥 Live vanuit Madrid met dagelijkse #ESMO2023 updates! 🇪🇸 Volg ons en blokkeer alvast 8/11 voor onze exclusieve Post-ESMO avond. Dé kans om dieper in de hoogtepunten te duiken en te netwerken. 👉medimix.be/post-esmo-2023… #MediMix #PostESMO2023 #ESMO2023 #oncologie #Oncology